Search

Qeen Biotechnologies (in partnership with Cellexus, CPI, University of Exeter, NRC Canada, and Unity Health Toronto) was awarded a $2M CAD grant through the Canada–UK: Biomanufacturing of Biologics and Advanced Therapies program to develop

Qeen Biotechnologies (Gatineau, Quebec) has announced the opening of its new 4,800 sq ft manufacturing facility designed for phage production, with operations starting as of September 2024.

The recording of the recent Clubhouse audio conversation on GMP phage therapy production (’Just say no to GMP?’) has just been posted! This was a talk hosted last week by Sabrina Green, Adriana Hernandez, Jean-Paul Pirnay, Patrick Druggan,

Check out this Twitter Q&A thread started by Paul Jaschke: "Anybody know of a source where cost of production ($/pfu) has been calculated for GMP or similar phage preps? #phagetherapy #bacteriophage #gmp".

Danish Malik (Loughborough University) and colleagues published a new paper in Current Opinion in Biotechnology showing current approaches for manufacture, formulation, targeted delivery and controlled release of phage-based therapeutics.

Apply to work as a full-time Manufacturing Technician to work on phage production process development, including establishment and execution of protocols to manufacture EPA-registered product.

We are urgently seeking Citrobacter freundii phages (and phage manufacturing capacity) for a patient in the USA. Ways to help at this stage: - By preparing clinical-grade phage preparations for this patient (one phage already identified,

BiomX, a phage therapy company in Israel, just announced the completion of its very own phage manufacturing facility! The facility will support clinical manufacturing of BiomX's candidate phage products, and could expand to support commerci

BiomX, a phage therapy company in Israel, just announced the completion of its very own phage manufacturing facility! The facility will support clinical manufacturing of BiomX's candidate phage products, and could expand to support commerci